Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

BACKGROUND: Anti-tumor necrosis factor (TNF) drugs have improved the prognosis for juvenile idiopathic arthritis (JIA) significantly. However, evidence for individual treatment decisions based on serum anti-TNF drug levels and the presence of anti-drug antibodies (ADAbs) in children is scarce. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassar-Sheikh Rashid, A., Schonenberg-Meinema, D., Bergkamp, S. C., Bakhlakh, S., de Vries, A., Rispens, T., Kuijpers, T. W., Wolbink, G., van den Berg, J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082819/
https://www.ncbi.nlm.nih.gov/pubmed/33926495
http://dx.doi.org/10.1186/s12969-021-00545-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082819/
https://www.ncbi.nlm.nih.gov/pubmed/33926495
http://dx.doi.org/10.1186/s12969-021-00545-x

Ejemplares similares